The intracellular signalling pathway signature (the signalome) in PBMCs in the presence of a common TRAPS-associated genetic variant, TNFRSF1A p.(Arg121Gln) (legacy p.R92Q) is distinct from normal PBMCs and from other pathogenic variants

Ítems similars

• Meningeal siderosis in a patient carrying the p.Arg92Gln variant TNFRSF1A gene
  per: F.J. Nicolás-Sánchez, et al.
  Publicat: (2022-04-01)
• A 56 year old woman with clinically significant p.Arg121Gln-/R92Q TNFRSF1A mutation
  per: von Mühlenen, I, et al.
  Publicat: (2015)
• Low-penetrance R92Q (p.Arg121Gln) mutation in the <i>TNFRSF1A</i> gene: the significance and variants of phenotypes. Successful experience with the interleukin-1 inhibitor canakinumab in a female patient, who is a carrier of R92Q mutation with a severe TRAPS phenotype
  per: E. S. Fedorov, et al.
  Publicat: (2020-09-01)
• Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity
  per: Fernández-Higuero, J. A., et al.
  Publicat: (2015)
• OR13-005 – Investigation of clinical and laboratory significance of TNFRSF1A intron by reverse-phase protein microarray
  per: Drewe, E, et al.
  Publicat: (2013)